Número 1 - EII al día

Revisiones
5. Loftus EV.Upper gastrointestinal tract Crohn´s disease. Clin Perspect Gastroenterol
2002;5:188-91.
6. Kefalas CH. Gastroduodenal Crohn´s disease. BUMC Proceedings
2003;16:147-51.
7. Yao K, Iwashita A, Yao T et al. Increased numbers of macrophages in noninflammed
gastroduodenal mucosa of patients with Crohn ´s disease.
Dig Dis Sci 1996;41: 2260-7.
8. Fenoglio-Preiser CM, Noffsinger AE, Stemmerman GN et al. The nonneoplastic
stomach . In Gastrointestinal Pathology, 2nd edition. Philadelphia:
Lippincott, 1999:153-236.
9. El Omar E, Penman I, Cruikshank G et al. Low prevalence of Helicobacter
Pylori in inflammatory bowel disease: association with sulfasalaze. Gut
1994;35:1385-8.
10. Oberhuber G, Hirsch M, Stole M. High incidence of upper gastrointestinal
tract involvement in Crohn´s disease. Virchows Arch 1998;
432:49-52.
11. Halme L, Karkkainen P, Rautelin H et al. High frecuency of Helicobacter
negative gastritis in patients with Crohn´s disease . Gut 1996,38:
379-83.
12. Gottlieb C, Albert S. Regional jejunitis. AJR 1937;38:881-3.
13. Farmer RG, Whelan G, Fazio VW. Long term follow up of patients with
Crohn´s disease : Relationship between the clinical pattern and prognosis.
Gastroenterology 1985;88:1818-25.
14. Tremaine WJ. Gastroduodenal Crohn´s diseae: medical management . Inflamm
Bowel Dis 2001;9(2):127-8.
15. Watgmans MJ, Verspaget HW, Lamers CBHW. et al. Clinical aspectos of
Crohn´ disease of the upper gastrointestinal tract: a comparision with distal
Crohn´s disease. Am J Gastroenterol 1997; 92:1467-71.
16. Lenaerts C, Roy CC, Vaillantcourt M et al. High incidence of upper gastrotestinal
tract involvement in children with Crohn´s disease. Pediatrics
1989;83:777-81.
17. Rutgeerts P,Onette E, Vantrappen G et al. Crohn´s disease of the stomach
and duodenum: a clinical study with emphasis on the value of endoscopy
and endoscopic biopsies. Endoscopy 1980;12: 288-94.
18. Reynolds HL, Strellato TA. Crohn´s disease of the foregut. Surg Clin North
Am 2001;81:117-35.
19. Levine MS. Crohn´s disease of the upper gastrointestinal tract. Radiol Clin
North Am 1987; 25:79-91.
20. Thompson WM,Cockrill H, Price RP. Regional enteritis of the duodenum.
Am J Roentgenol 1975;123:252-61.
21. Foutch PG, Ferguson DR. Duodenal Crohn´s disease complicated by common
bile duct obstruction: report of a case and review of the literature.
Am J Gastroenterol 1984;79:520-4.
22. Farman J, Faegenburg D, Dallemand S et al. Crohn´s disease of the stomach:
the “ ram´s horn” sign. Am J Roentgenol Radium Ther Nucl Med
1975;683-8.
23. Greenstein AJ, Present DH, Sachar DB et al. Gastric fistulas in Crohn´s disease.
Report of cases. Dis Colon Rectum 1989;32:888-92.
24. Simmonds SD, Pitman RG, Machan L et al. Duodenopancreatic fistula accompanying
Crohn´s disease of the distal duodenum. Am J Gastroenterol
1989;84:800-3.
25. Meltzer SSJ, Korelitz BI. Pancreatitis and duodenopancreatic reflux in
Crohn´s disease: case report and review of the literatur. J Clin Gastroenterol
1988;10:555-8.
26. NewmanLH, Welinger JR, Present DH et al. Crohn´s disease of the duodenum
associated with pancreatitis : a case report of the literature. Mt
Sinai J Med 1987;54:429-32.
27. Mottet C, Juillerat P, Gonvers JJ et al. Treatment of gastroduodenal Crohn´s
disease. Digestion 2005;71:37-40.
28. Valori RM, Cockel R. Omeprazole for duodenal ulceration in Crohn´s disease.
Br Med J 1990;300:438-9.
29. Woolson K, Greenbeg GR. Symptomatic improvement of gastroduodenal
Crohn´s disease with ompeprazole. Can J Gastroenterol 1992;6:21-4.
30. Bianchi Porro G, Ardizzone S, Petrillo M et al. Omeprazole for peptic ulcer
in Crohn´s disease ( letter). Am J Gastroenterol 1991;86:245-6.
31. Miehhsler W, Puspok A, Oberhuber G et al. Impact of different therapeutic
regimens on the outcome of patients with Crohn´s disease of hte upper
gastrointetsinal tract. Inflamm Bowel Dis 2001;7 (2):99-105.
32. Meddings JB, Sutherland LR , Byles NI et al. Sucrose: a novel permeability
marker for gastroduodnal disease. Gastroenterology 1993;104:1619-26.
33. Sutherland LR , Verhoef M, Wallace JL et al. A simple non invasive marker
of gastric damage: sucrose permeability . Lancet 1994;343:998-100.
34. Griiths AM, Alemayehu E, Sherman P. Clinical features of gastroduodenal
Crohn´s disease in adolescents. J Pediatr Gastroenterol Nutr 1989;8:166-71.
35. Korelitz BI, et al. Long term experience with 6 mercaptopurine in the treatment
of Crohn´s disease . Am J Gastroentrol 1993; 88:1198-1205.
36. Sandborn WJ. Preliminary report on the use of oral tacrolimus ( FK 506)
in the treatment of complicated proximal small bowel and fistulizing
Crohn´s disease. Am J Gastroentrol 1997,92: 876-9.
37. Heller T et al. Treatment of severe esophageal Crohn´s disease with iNfliximab.
Inflamm Bowel Dis 1999; 5:279-82.
38. Ho IK, ET AL. Infliximab treatment of an esophagobronchial fistula in a
patient with extensive Crohn´s disease of the esophagus. J Clin Gastroenterol
2002; 34:488-9.
39. Firth JJ, Prather C. Unusual gastric Crohn´s disease treated with Infliximab.
A case report. Am J Gastroenterol 2002;97:S190.
40. Grubel P ET AL. Severe isolated Crohn´s - like disease of the gastroduodenal
tract. Dig Dis Sci 2003; 48:1360-5.
41. Knapp AB, Mirsky FJ, Dillon EH et al. Successful Infliximab therapy for a
duodenal stricture caused by Crohn´s disease.Inflamm Bowel Dis
2005;12:1123-5.
42. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn´s disease
strictures . Inflamm Bowel Dis 2004;10:55-60.
43. Di Sabatino A, Ciccocioppo R, Benazzato L et al. Infliximab down-regulates
basic fibroblast growth factor and vascular endothelial growth factor
in Croh´s disease patients. Aliment Pharmacol Ther 2004; 19:1019-24.
44. Hanauer SB, Feagan BG, Lichenstein GR et al. Maintenance Infliximab for
Crohn´s disease: the ACCENT I randomized trial. Lancet 2002;359:1541.
45. Matsui T et al. Long-term outcome of endoscopic balloon dilatation in
obstructive gastroduodenal Crohn´s disease. Endoscopy 1997;29(7):640-
5.
46. Murthy UK. Repeated hydrostatic balloon dilatation in obstructive gastroduodenal
Crohn´s disease . Endoscopy 1997;29:640-5.
47. Reynolds HL, Strellato TA. Crohn´s disease of the foregut. Surg Clin North
Am 2001;81:117-35, viii.
48. Salky B. Severe gastroduodenal Crohn´s disease : surgical treatment. Inflamm
Bowel Dis 2003;9:129-30.
49. Pace BW, Bank S, Wise L. Stricturoplasty . An alternative in the surgical
treatment of Crohn´s disease. Arch Surg 1984;119:861-2.
50. Worsey MJ , Hull T, Ryland L et al. Strictureplasty is an effective option in
the operative management of duodenal Crohn´s disease. Dis Colon Rectum
1999;42: 596-600.
51. Yamamoto T, Brain IM, Connolly AB et al. Outcome of stricturoplasty for
duodenal Crohn´s disease Br J Surg 1999,86:259-62.
9 • Enfermedad Inflamatoria Intestinal al día - Vol. 6 - Nº. 1 - 2007